TP53 and osteosarcoma: Overall, given that recent advances in technology have resulted in the more frequent detection of p53 mutations, it is important to examine the biological roles of mutant p53 using preclinical models and reevaluate the clinical significance of p53 alterations in response to chemotherapy and metastasis in human osteosarcoma.